
GL Stock Forecast & Price Target
GL Analyst Ratings
Bulls say
Globe Life Inc. is poised for solid growth, with life premium growth projected at 4.0%-4.5% and health premiums expected to increase significantly by 14%-16% in the upcoming year, driven by enhanced marketing efforts and lead generation. Notably, a strong performance in mortality experience contributed to a substantial remeasurement gain of $150 million in the third quarter, reflecting favorable conditions within both life and health sectors. Additionally, management's upward revision of the 2025 EPS estimate to $14.50 indicates confidence in sustained profitability and aligns well with the company's long-term growth strategy.
Bears say
Globe Life Inc. projects operating earnings per share to grow only 3% at the midpoint by 2026, a significant reduction driven by updated assumptions and a substantial drop in expected life remeasurement gains, declining from $192 million to a range of $50-$100 million. The company is also facing several risks, including potential fines or reputational damage from an ongoing EEOC review, increased margin pressure due to rising health utilization, and challenges in recruiting a productive sales force. Furthermore, the anticipated underwriting margins for the Life segment are expected to be modest, while the Health segment's margins are predicted to be adversely affected by a shift towards lower-profit Medicare Supplement products.
This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.
GL Analyst Forecast & Price Prediction
Start investing in GL
Order type
Buy in
Order amount
Est. shares
0 shares